Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Dutch study of 35-yr trends in incidence/survival for myeloma finds significant survival improvements in each age group but age-related differences persist related to comorbidities & diminished treatment tolerability.”
Title: Multiple myeloma in the Netherlands: 35-year trends in incidence and survival
Authors: Koen M. Klomberg, Wilfried W. H. Roeloffzen, Marcel Nijland, Mark-David Levin, Inger S. Nijhof, Rimke Oostvogels, Elizabeth de Kort, Ruth Wester, Catharina H. M. J. van Elssen, Esther G. M. de Waal, Paul A. F. Geerts, Yavuz M. Bilgin, Djamila E. Issa, Marjolein van de Klift, Gerwin A. Huls, Laurens E. Franssen, Cleo R. van Rooijen, Monique C. Minnema, Annemiek Broijl, Paula F. Ypma, Niels W. C. J. van de Donk, Sonja Zweegman, Mirian Brink, Wouter J. Plattel
You can read the full article on Leukemia.
You can find other articles featuring Robert Orlowski on OncoDaily.
